Korenberg Matthew E sold LGND
January 2, 2024 · Form 4 insider transaction
Korenberg Matthew E sold 2,917 shares of Ligand Pharmaceuticals Incorporated at $72.31 per share, a transaction worth $210.9K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
2,917
Price
$72.31
Total value
$210.9K
InsiderKorenberg Matthew E
Role—
SecurityCommon Stock
Transaction codeF: Shares withheld for taxes
Transaction dateJanuary 2, 2024
Filing dateJanuary 4, 2024
Shares owned after94,223
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of restricted stock units.